Even with promising results in humans paired with dramatic results in earlier tests in primates, a gene therapy treating Parkinson's disease, first developed in 1997, is heading back to the drawing board. Here's why.
Even with promising results in humans paired with dramatic results in earlier tests in primates, a gene therapy treating Parkinson's disease, first developed in 1997, is heading back to the drawing board. Here's why.